François is a veteran executive with 30 years of experience in advanced cell and gene therapy product development across multiple therapeutic areas. His background includes leadership roles in both startups and major healthcare organizations. He previously served as President of Renovaro Biosciences, CEO of Rediens, and Global Head of Product Development at Lineage Cell Therapeutics, with prior experience at Johnson & Johnson, Medtronic, and Genzyme.

Michael is a physician-scientist with over 25 years of experience in internal medicine, developmental biology, and drug development. He has held senior leadership roles in both biotech startups and major pharma, including Centocor, Johnson & Johnson, and Incyte. He co-founded the Proof-of-Concept Team at J&J and led Global Medical Affairs at Incyte.

Dave Whelan has devoted his career to building businesses and inspiring entrepreneurs at the intersection of technology, health, and wellness. Dave works with organizations and entrepreneurs across the country and around the world, through his consultancy Bespoke Strategy, as well as collaborations with Wavemaker Three-Sixty Health and Big4Bio. He has held senior roles with BioscienceLA and New York Genome Center, among others. He hold an MBA from UCLA Anderson School and a BS Symbolic Systems from Stanford University.

Stealth

Dr. Saeed Sadeghi is a hematologist and medical oncologist in Santa Monica, specializing in breast, gynecological, and hepatobiliary cancers. Board-certified in internal medicine, hematology, and oncology, he participates in UCLA Health clinical trials and has led research on breast and hepatobiliary cancers. Dr. Sadeghi received his medical degree from the St. Louis University School of Medicine. He then completed his internal medicine residency at the Los Angeles County+USC Medical Center, followed by his hematology-oncology fellowship at UCLA.